Skip to main content

Find Clinical Trials

Home
Conditions
Neurofibroma

Clinical trial condition

Neurofibroma

Explore clinical trials studying Neurofibroma. Study availability and eligibility vary by location and protocol.

238 public trials 41 recruiting studies

Refine in advanced search Browse all conditions

Neurofibroma trial results

Completed

Quality of Friendships in Children With Neurofibromatosis

NCT00508235

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +11 more
Locations: U.T.M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma

NCT00041236

Conditions: Fibrosarcoma, Hemangiopericytoma, Malignant, Hemangiosarcoma, +25 more
Locations: Cliniques Universitaires Saint-Luc Brussels, Belgium

U.Z. Gasthuisberg Leuven, Belgium

Aarhus University Hospital - Aarhus Sygehus - Norrebrogade Aarhus, Denmark

Robert Roessle Comprehensive Cancer Center at University of Berlin - Charite Campus Buch Berlin, Germany

View Trial Details

Completed

Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

NCT00041249

Conditions: Digestive System Diseases, Digestive System Neoplasms, Fibrosarcoma, +31 more
Locations: Universitair Ziekenhuis Antwerpen Edegem, Belgium

U.Z. Gasthuisberg Leuven, Belgium

Centre Leon Berard Lyon, France

CHU de la Timone Marseille, France

View all 16 locations

View Trial Details

Completed

Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma

NCT00002764

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +62 more
Locations: Lund University Hospital Lund, Sweden

View Trial Details

Completed

Clinical Trial of Pirfenidone in Adult Patients With Neurofibromatosis 1

NCT00754780

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +16 more
Locations: Not specified

View Trial Details

Completed

Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma

NCT00003212

Conditions: Fibrosarcoma, Hemangiopericytoma, Malignant, Hemangiosarcoma, +25 more
Locations: Universitair Ziekenhuis Antwerpen Edegem, Belgium

U.Z. Gasthuisberg Leuven, Belgium

Aarhus Kommunehospital Aarhus, Denmark

Rigshospitalet Copenhagen, Denmark

View all 23 locations

View Trial Details

Completed

NF1-Attention: Study of Children With Neurofibromatosis Type 1 Treated by Methylphenidate

NCT00169611

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +14 more
Locations: Laurence LION-FRANCOIS Lyon, France

View Trial Details

Terminated

Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas

NCT05130866

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +25 more
Locations: House Institute Los Angeles, California, United States

University of California Los Angeles Los Angeles, California, United States

Children's National Hospital Washington D.C., District of Columbia, United States

University of Florida Gainesville, Florida, United States

View all 15 locations

View Trial Details